Lipin‐2 regulates the antiviral and anti‐inflammatory responses to interferon
EMBO reports · 2023
DOI: 10.15252/embr.202357238 ↗Kurz gefasst
Fachartikel in der Zeitschrift EMBO reports, 2023. Verfasst von Nagore de Pablo und 8 weiteren Autor:innen. Beteiligte Einrichtung: Instituto de Biología y Genética Molecular, Consejo Superior de Investigaciones Científicas (CSIC), Valladolid, Spain. Hauptthemen laut MEDLINE: DNA, Mitochondrial, Interferons. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 95 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Centro de Investigación Biomédica en Red Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Consejería de Educación, Junta de Castilla y León (Ministry of Education, Government of Castile-Leon), Junta de Castilla y León (JCYL).
Abstract (Originalsprache)
Interferons (IFN) are crucial antiviral and immunomodulatory cytokines that exert their function through the regulation of a myriad of genes, many of which are not yet characterized. Here, we reveal that lipin‐2, a phosphatidic acid phosphatase whose mutations produce an autoinflammatory syndrome known as Majeed syndrome in humans, is regulated by IFN in a STAT‐1‐dependent manner. Lipin‐2 inhibits viral replication both in vitro and in vivo . Moreover, lipin‐2 also acts as a regulator of inflammation in a viral context by reducing the signaling through TLR3 and the generation of ROS and release of mtDNA that ultimately activate the NLRP3 inflammasome. Inhibitors of mtDNA release from mitochondria restrict IL‐1β production in lipin‐2‐deficient animals in a model of viral infection. Finally, analyses of databases from COVID‐19 patients show that LPIN2 expression levels negatively correlate with the severity of the disease. Overall, these results uncover novel regulatory mechanisms of the IFN response driven by lipin‐2 and open new perspectives for the future management of patients with LPIN2 mutations.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Instituto de Biología y Genética Molecular, Consejo Superior de Investigaciones Científicas (CSIC), Valladolid, Spain.
- Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Instituto de Salud Carlos III, Madrid, Spain.
- Immunology Unit, Department of Biomedical Sciences, Faculty of Medicine and Health Sciences, University of Barcelona, Barcelona, Spain.
- Institut d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain.
- Departamento de Medicina Preventiva y Salud Pública, Facultad de Medicina, Universidad Autónoma de Madrid, Madrid, Spain.
ORCID-Profile: Nagore de Pablo, Javier Martínez-García, Pablo Martínez-Vicente, Manuel Albert, Susana Guerra, Ana Angulo, Jesús Balsinde, María A Balboa
Förderung
- Centro de Investigación Biomédica en Red Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM)
- Consejería de Educación, Junta de Castilla y León (Ministry of Education, Government of Castile-Leon)
- Junta de Castilla y León (JCYL)
- Ministerio de Ciencia e Innovación (MCIN)
- Ministerio de Ciencia, Innovación y Universidades (MCIU)
- Ministerio de Economia, Industria y Competitividad
Zitieren
APA
de Pablo, N., Meana, C., Martínez-García, J., Martínez-Vicente, P., Albert, M., Guerra, S., Angulo, A., Balsinde, J., & Balboa, M. A. (2023). Lipin‐2 regulates the antiviral and anti‐inflammatory responses to interferon. EMBO reports. https://doi.org/10.15252/embr.202357238
Vancouver
de Pablo N, Meana C, Martínez-García J, Martínez-Vicente P, Albert M, Guerra S, et al. Lipin‐2 regulates the antiviral and anti‐inflammatory responses to interferon. EMBO reports. 2023. doi:10.15252/embr.202357238
BibTeX
@article{dePablo2023,
author = {de Pablo, Nagore and Meana, Clara and Martínez-García, Javier and Martínez-Vicente, Pablo and Albert, Manuel and Guerra, Susana and Angulo, Ana and Balsinde, Jesús and Balboa, María A},
title = {Lipin‐2 regulates the antiviral and anti‐inflammatory responses to interferon},
journal = {EMBO reports},
year = {2023},
doi = {10.15252/embr.202357238}
}
EUVIMED